Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)

Published:2024-08-27 Issue:9 Volume:17 Page:817-835
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Aribindi Katyayini¹²^ORCID,Liu Gabrielle Y.¹^ORCID,Albertson Timothy E.¹²^ORCID

Affiliation:

1. Department of Internal Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA

2. Department of Medicine, Department of Veterans Affairs Northern California Health Care System, Mather, CA, USA

Funder

NHLBI

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2024.2396121

Reference196 articles.

1. Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?

2. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

3. The genetic basis of idiopathic pulmonary fibrosis

4. Epidemiology of idiopathic pulmonary fibrosis

5. The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP